Sedivention GmbH

This content was machine translated.

About Sedivention GmbH

Severe obesity causes more than 400,000 deaths annually and society-wide costs exceeding 2 trillion dollars worldwide. Yet there is a lack of scalable, affordable, and easily accessible therapy. Sedivention’s idea is to develop a broadly applicable interventional therapy comparable to a gastroscopy. Hunger is one of the main drivers of overeating and obesity. Hunger is mediated to the brain via the vagus nerve. Sedivention is developing a cryoballoon that ablates the vagus nerve from the stomach. This outpatient intervention takes approximately 20 minutes, costs significantly less than gastric bypass surgery, and does so without the morbidity and complications. In short: Sedivention is developing the first effective and scalable therapy for obesity. No scars, no pain, no surgical complications, no access barriers, no implants at an affordable price.

Discover more articles, startups, and events from the ecosystem

Ecosystem

Munich Startup Recap 38/26

20.09.26

2 Min.

Deals

Faster Wildfire Detection: Ororatech Partners with Eutelsat

18.09.26

3 Min.

Interviews

Project-S Uses Radar to Ensure a Safe Orbit

18.09.26

4 Min.

Online Event

Online: Specialist Workshop: Typical Clauses in Investment Agreements

September 22, 2026

05:00 PM – 08:00 PM

Online

Online Event

Online: Tutorial: From Idea to Product Development

September 23, 2026

01:30 PM – 02:30 PM

Online

Air2Growth

Air2Growth is developing an innovative system that converts CO2 emissions directly on-site into high-quality organic fertilizer. Using advanced microalgae technology, we create a closed circular economy that enables more sustainable, independent, and economical agriculture. Our solution specifically targets greenhouse operators as well as modern agricultural businesses. By directly utilizing exhaust gases and CO2 sources, our customers not only actively lower their environmental footprint, but also noticeably reduce their ongoing fertilizer costs at the same time. In times of fluctuating market prices and uncertain supply chains, Air2Growth makes businesses independent of fossil raw materials and synthetic imports. In this way, we combine effective climate protection with concrete economic benefits and strengthen the future viability of regional food production.

NeoSoma

At NeoSoma, we empower individuals by restoring full control over their health data. Our open-access tracker ensures that users own their data and decide precisely who may access them – without subscription barriers or vendor lock-in. For research our device provides raw signal output, configurable sampling rates and duty cycles, and full transparency of sensor streams. We believe that health tracking should serve the individual first – your body, your data, your decisions – while offering the same professional-grade foundation for science and discovery.

rnhale

RNhale develops inhaled RNA therapeutics for COPD and severe asthma. Our platform transforms RNA-loaded lipid nanoparticles into an inhalable dry powder, enabling direct, local delivery to the lungs. By addressing the key challenges of pulmonary RNA delivery, stability, deep lung deposition, and cellular uptake, our technology unlocks a more effective path for RNA-based therapies to reach their target. Our goal is to develop effective, locally-acting respiratory therapies that address disease at its molecular source. Our vision: to redefine the treatment of severe lung diseases.